The Impact of Rheumatologist-performed Ultrasound on Diagnosis and Management of Inflammatory Arthritis in Routine Clinical Practice
Overview
- Phase
- Not Applicable
- Intervention
- DMARD
- Conditions
- Arthritis, Rheumatoid
- Sponsor
- Barts & The London NHS Trust
- Enrollment
- 258
- Primary Endpoint
- To compare the time from first visit to treatment initiation between patients with and without rheumatologist-performed ultrasound assessment
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
The aim of this research study is to describe the impact of rheumatologist performed ultrasound on the diagnosis and management pathways of patients with rheumatoid arthritis. Primarily, to compare the time from first visit to treatment initiation between patients with and without rheumatologist-performed ultrasound assessment.
Detailed Description
There are currently no guidelines for best practice in the use of ultrasound in RA and interim results from a survey by the British Society of Rheumatology (BSR) in this area have suggested that practice is variable across the UK. NICE recognize that the earlier persistent synovitis is identified and treated with disease modifying anti-rheumatic drugs DMARDs, the better the long term outcome and have welcomed the need to determine the role of imaging in assisting with this early diagnosis, and whether the added cost is justified by better disease outcomes. This is a multi-site prospective observational study which investigates the use of ultrasound imaging in the context of patients with early arthritis presenting to secondary care. The time to commencement of DMARD therapy and diagnosis of Rheumatoid arthritis are therein outcome measures. Patients are followed up for 12 months after their first presentation and time to diagnosis or DMARD commencement recorded.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients aged ≥18 years at the time of presentation to the clinic Patients newly presenting to the rheumatology clinic with suspected inflammatory arthritis
Exclusion Criteria
- •For the non-ultrasound arm; patients who have been referred to another rheumatologist or radiologist for ultrasound Patients who decline or who are unable to consent to the use of their medical records for research
Arms & Interventions
Ultrasound
Early Arthritis Patients seeing a Rheumatologist who uses US for assessment routinely in clinic
Intervention: DMARD
Non-Ultrasound
Early Arthritis Patients seeing a Rheumatologist who does not uses US for assessment routinely in clinic
Intervention: DMARD
Outcomes
Primary Outcomes
To compare the time from first visit to treatment initiation between patients with and without rheumatologist-performed ultrasound assessment
Time Frame: 12 months